Overview

Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Naive Subjects

Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if buprenorphine hydrochloride (HCl) buccal film is effective in treating opioid-naive subjects, with moderate to severe chronic low back pain (CLBP), who require continuous around-the-clock (ATC) pain relief for an extended period of time.
Phase:
Phase 3
Details
Lead Sponsor:
BioDelivery Sciences International
Endo Pharmaceuticals
Collaborator:
BioDelivery Sciences International
Treatments:
Buprenorphine